MDT
Medtronic plc
$80.28
-2.07%
$105.3B
No data for this timeframe.
Vol
Market Cap$105.3B
Cap SizeLarge Cap
Analyst ConsensusBuy (57%)
Insider Activity0B / 1S
Insider Net $-$318.6K
Reddit Sentiment63° Warm
SEC Reports6
Congressional1 trades
Recent Activity
Jun 8, 2026
Insider
KIIL HARRY SKIP sold 3,961 shares
EVP & President Cardiovascular @ $80.44 ($318.6K)
Jun 5, 2026
Insider
Blomquist Denise L. sold 237 shares
Chief Accounting Officer @ $83.32 ($19.7K)
Jun 4, 2026
SEC
BTIG upgrades MDT to Buy — PT $90 (+15.5%)
ANALYST-UPGRADE — Impact 2/10
Jun 4, 2026
Insider
KIIL HARRY SKIP sold 6,817 shares
EVP & President Cardiovascular @ $83.32 ($568.0K)
Jun 3, 2026
earnings_calendar
MDT Q4 2026 Earnings After Market Close — 2026-06-03
May 31, 2026
SEC
9 firms acted on MDT: Needham, William Blair, Goldman Sachs, Wolfe Research, Leerink Partners, Citigroup, RBC Capital, UBS, Stifel
ANALYST-UPGRADE — Impact 1/10
May 19, 2026
Event
Recor Medical, Inc. v. Medtronic Ireland Manufacturing Unlimited Co.
Court ruling from Court of Appeals for the Federal Circuit. Docket: 25-1998
May 1, 2026
SEC
Needham upgrades MDT to Buy — PT $121 (+49%) as 10-firm analyst cluster converges on medtech giant
ANALYST-UPGRADE — Impact 3/10
Price Targets
$98.58
+22.8% upside
Strong Buy
Current $80.28
Low $78.00
Median $100.50
High $121.00
26 analysts
$78.00
$121.00
Analyst Ratings
8Strong Buy
13Buy
15Hold
1Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 5, 2026 | Goldman Sachs | MAINTAIN | Neutral → Neutral |
| Jun 5, 2026 | Bernstein | MAINTAIN | Outperform → Outperform |
| Jun 4, 2026 | UBS | MAINTAIN | Neutral → Neutral |
| Jun 4, 2026 | TD Cowen | REITERATE | Buy → Buy |
| Jun 4, 2026 | RBC Capital | REITERATE | Outperform → Outperform |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $1.39 ▲ +0.5% | $1.38 — $1.40 | 10% YoY | 24 |
| Next Q | $1.35 ▼ -5.8% | $1.32 — $1.41 | -1% YoY | 24 |
| Current FY | $5.95 | $5.88 — $6.02 | 8% YoY | 27 |
| Next FY | $6.41 | $6.20 — $6.65 | 8% YoY | 28 |
Latest Reports
BULLISH
ANALYST-UPGRADE
1/10
9 firms acted on MDT: Needham, William Blair, Goldman Sachs, Wolfe Research, Leerink Partners, Citigroup, RBC Capital, UBS, Stifel
May 31, 2026
BULLISH
ANALYST-UPGRADE
3/10
Needham upgrades MDT to Buy — PT $121 (+49%) as 10-firm analyst cluster converges on medtech giant
May 1, 2026
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 8, 2026 | KIIL HARRY | SELL | $318.6K |
| Jun 5, 2026 | Blomquist Denise | F | $19.7K |
| Jun 4, 2026 | KIIL HARRY | F | $568.0K |
| Jun 4, 2026 | Marinaro Michael | F | $622.5K |
| Jun 4, 2026 | Walter Matthew | F | $236.6K |
Reddit Sentiment
63°
Warm
Bearish
Neutral
Bullish
Congressional Trades
1 members: 0 buys, 1 sells
| Member | Party | Type | Amount |
|---|---|---|---|
| Kevin Hern | R | SELL | $15,001 - $50,000 |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
12 unique insiders with 1 transactions. Net insider value: -$318.6K ($0.00 bought, $318.6K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 8, 2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | SELL | 3,961 | $80.44 | $318.6K |
| Jun 5, 2026 | Blomquist Denise L. | Chief Accounting Officer | F | 237 | $83.32 | $19.7K |
| Jun 4, 2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | F | 6,817 | $83.32 | $568.0K |
| Jun 4, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | F | 7,471 | $83.32 | $622.5K |
| Jun 4, 2026 | Walter Matthew R. | SVP, Chief HR Officer | F | 2,840 | $83.32 | $236.6K |
| Jun 4, 2026 | Martha Geoffrey | Chairman and CEO | F | 41,936 | $83.32 | $3.5M |
| May 26, 2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | M | 15,195 | $0.00 | $0.00 |
| May 26, 2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | M | 14,517 | $0.00 | $0.00 |
| May 26, 2026 | Blomquist Denise L. | Chief Accounting Officer | M | 1,712 | $0.00 | $0.00 |
| May 26, 2026 | Blomquist Denise L. | Chief Accounting Officer | M | 1,621 | $0.00 | $0.00 |
| May 26, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | M | 18,994 | $0.00 | $0.00 |
| May 26, 2026 | Marinaro Michael | EVP, Pres MedSurg and Americas | M | 17,093 | $0.00 | $0.00 |
| May 26, 2026 | Martha Geoffrey | Chairman and CEO | M | 85,461 | $0.00 | $0.00 |
| May 26, 2026 | Martha Geoffrey | Chairman and CEO | M | 94,963 | $0.00 | $0.00 |
| May 26, 2026 | Wall Brett A. | EVP & Pres Neuroscience | M | 24,214 | $0.00 | $0.00 |
| May 26, 2026 | Wall Brett A. | EVP & Pres Neuroscience | M | 26,907 | $0.00 | $0.00 |
| May 26, 2026 | Walter Matthew R. | SVP, Chief HR Officer | M | 9,149 | $0.00 | $0.00 |
| May 26, 2026 | Walter Matthew R. | SVP, Chief HR Officer | M | 8,449 | $0.00 | $0.00 |
| May 1, 2026 | Walter Matthew R. | SVP, Chief HR Officer | F | 35 | $80.00 | $2.8K |
| Apr 28, 2026 | NABEL ELIZABETH G | Director | F | 207 | $81.90 | $17.0K |
| Apr 28, 2026 | Lofton Kevin E | Director | F | 207 | $81.90 | $17.0K |
| Apr 28, 2026 | Lewis Gregory P | Director | F | 207 | $81.90 | $17.0K |
| Apr 28, 2026 | Powell Kendall J | Director | F | 207 | $81.90 | $17.0K |
| Apr 28, 2026 | Blomquist Denise L. | Chief Accounting Officer | F | 318 | $81.90 | $26.0K |
| Apr 27, 2026 | NABEL ELIZABETH G | Director | A | 2,111 | $0.00 | $0.00 |
| Apr 27, 2026 | Lofton Kevin E | Director | A | 2,111 | $0.00 | $0.00 |
| Apr 27, 2026 | Lewis Gregory P | Director | A | 2,111 | $0.00 | $0.00 |
| Apr 27, 2026 | Lee Joon Sup | Director | A | 1,803 | $0.00 | $0.00 |
| Apr 27, 2026 | Blomquist Denise L. | Chief Accounting Officer | A | 1,508 | $0.00 | $0.00 |
| Apr 27, 2026 | Powell Kendall J | Director | A | 2,111 | $0.00 | $0.00 |
| Mar 3, 2026 | Pieton Thierry | EVP & Chief Financial Officer | F | 2,976 | $96.71 | $287.8K |
| Feb 20, 2026 | Blomquist Denise L. | Chief Accounting Officer | G | 340 | $0.00 | $0.00 |
| Feb 19, 2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | M | 30,568 | $93.08 | $2.8M |
| Feb 19, 2026 | KIIL HARRY SKIP | EVP & President Cardiovascular | M | 30,568 | $0.00 | $0.00 |
| Jan 29, 2026 | Blomquist Denise L. | Chief Accounting Officer | F | 148 | $101.00 | $14.9K |
6 SEC filing reports analyzed. Sentiment: 5 bullish, 0 bearish, 1 mixed, 0 neutral. Avg impact: 3.8/10.
BULLISH
ANALYST-UPGRADE
3/10
Needham upgrades MDT to Buy — PT $121 (+49%) as 10-firm analyst cluster converges on medtech giant
May 1, 2026
BULLISH
ANALYST-UPGRADE
1/10
9 firms acted on MDT: Needham, William Blair, Goldman Sachs, Wolfe Research, Leerink Partners, Citigroup, RBC Capital, UBS, Stifel
May 31, 2026
BULLISH
ANALYST-UPGRADE
2/10
BTIG upgrades MDT to Buy — PT $90 (+15.5%)
Jun 4, 2026
BULLISH
8-K
6/10
Medtronic reported Q4 FY26 revenue of $9.807B (+9.9% YoY, +6.6% organic), beating the $9.61B consens
Jun 3, 2026
BULLISH
COURT-RULING
5/10
The Federal Circuit reversed the district court's dismissal of Medtronic Ireland's patent infringeme
May 19, 2026
MIXED
COURT-RULING
6/10
A federal court found that Medtronic failed to timely institute legal holds for nine key employees i
Apr 6, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Hold (57% buy). Based on 37 analysts: 8 strong buy, 13 buy, 15 hold, 1 sell, 0 strong sell.
Analyst Price Targets
$98.58 mean target
+22.8% upside
Strong Buy (1.90)
$78.00 Low
$121.00 High
| Metric | Value |
|---|---|
| Current Price | $80.28 |
| Target Low | $78.00 |
| Target Mean | $98.58 |
| Target Median | $100.50 |
| Target High | $121.00 |
| # Analysts | 26 |
| Recommendation | Strong Buy (1.90) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-07-31 |
$1.39 | $1.38 | $1.40 | 10.1% | +0.5% | 5↑ 4↓ | $9.6B | 11.9% | 24 |
| Next Q 2026-10-31 |
$1.35 | $1.32 | $1.41 | -0.9% | -5.8% | 0↑ 19↓ | $9.5B | 6.0% | 24 |
| Current FY 2027-04-30 |
$5.95 | $5.88 | $6.02 | 7.6% | — | 0↑ 23↓ | $38.8B | 6.9% | 27 |
| Next FY 2028-04-30 |
$6.41 | $6.20 | $6.65 | 7.8% | — | 1↑ 21↓ | $40.1B | 3.2% | 28 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $1.388 | |
| 7d ago | $1.388 | -0.000 |
| 30d ago | $1.380 | +0.007 |
| 60d ago | $1.379 | +0.009 |
| 90d ago | $1.377 | +0.010 |
19 analyst firms have rated this stock: 3 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 5, 2026 | Goldman Sachs | MAINTAIN | Neutral | Neutral |
| Jun 5, 2026 | Bernstein | MAINTAIN | Outperform | Outperform |
| Jun 4, 2026 | UBS | MAINTAIN | Neutral | Neutral |
| Jun 4, 2026 | TD Cowen | REITERATE | Buy | Buy |
| Jun 4, 2026 | RBC Capital | REITERATE | Outperform | Outperform |
| Jun 4, 2026 | Wells Fargo | MAINTAIN | Overweight | Overweight |
| Jun 4, 2026 | Leerink Partners | MAINTAIN | Outperform | Outperform |
| Jun 4, 2026 | Baird | MAINTAIN | Neutral | Neutral |
| Jun 4, 2026 | BTIG | UPGRADE | Neutral | Buy |
| Jun 3, 2026 | Mizuho | MAINTAIN | Outperform | Outperform |
| Jun 3, 2026 | Needham | MAINTAIN | Buy | Buy |
| Apr 22, 2026 | UBS | MAINTAIN | Neutral | Neutral |
| Apr 15, 2026 | Truist Securities | MAINTAIN | Hold | Hold |
| Apr 13, 2026 | Mizuho | MAINTAIN | Outperform | Outperform |
| Apr 9, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Apr 7, 2026 | Citigroup | MAINTAIN | Buy | Buy |
| Apr 6, 2026 | Evercore ISI Group | MAINTAIN | Outperform | Outperform |
| Apr 6, 2026 | Argus Research | MAINTAIN | Buy | Buy |
| Apr 1, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Apr 1, 2026 | Piper Sandler | MAINTAIN | Neutral | Neutral |
| Mar 26, 2026 | Needham | REITERATE | Buy | Buy |
| Mar 10, 2026 | Needham | REITERATE | Buy | Buy |
| Feb 18, 2026 | JP Morgan | MAINTAIN | Neutral | Neutral |
| Feb 18, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Feb 18, 2026 | Baird | MAINTAIN | Neutral | Neutral |
| Feb 17, 2026 | Needham | MAINTAIN | Buy | Buy |
| Feb 9, 2026 | Needham | UPGRADE | Hold | Buy |
| Feb 4, 2026 | UBS | MAINTAIN | Neutral | Neutral |
| Jan 9, 2026 | Bernstein | MAINTAIN | Outperform | Outperform |
| Jan 8, 2026 | Barclays | MAINTAIN | Overweight | Overweight |
| Jan 6, 2026 | William Blair | UPGRADE | Market Perform | Outperform |
| Dec 18, 2025 | Truist Securities | MAINTAIN | Hold | Hold |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 8 | 13 | 15 | 1 | 0 | 57% | |
| May 1, 2026 | 8 | 15 | 13 | 1 | 0 | 62% | |
| Apr 1, 2026 | 8 | 15 | 13 | 1 | 0 | 62% | |
| Mar 1, 2026 | 8 | 16 | 13 | 1 | 0 | 63% | |
| Feb 1, 2026 | 7 | 13 | 14 | 1 | 0 | 57% | |
| Jan 1, 2026 | 7 | 14 | 16 | 1 | 0 | 55% | |
| Dec 1, 2025 | 7 | 13 | 18 | 1 | 0 | 51% | |
| Nov 1, 2025 | 7 | 13 | 17 | 2 | 0 | 51% |
Strong BuyBuyHoldSellStrong Sell
1 members of Congress traded this stock: 0 buys, 1 sells.
Congressional Trades
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | Kevin Hern | R | HOUSE | SELL | $15,001 - $50,000 | Medtronic PLC | Apr 6, 2026 (18d) |
63°
Warm
Bearish
Neutral
Bullish
4 mentions
2 bullish
0 bearish
4 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| Jun 3, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| Jun 3, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
| May 11, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 11, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
Recent Reddit Threads
Medtronic’s turnaround is getting harder to ignore.
▲ 1
💬 0
⚡ 0.5
Jun 3, 2026
earnings_calendar
MDT Q4 2026 Earnings After Market Close — 2026-06-03
May 20, 2026
earnings_calendar
MDT Q4 2026 Earnings After Market Close — 2026-05-20
EPS est: $1.67 | Rev est: $9.7B
May 19, 2026
Enforcement
Recor Medical, Inc. v. Medtronic Ireland Manufacturing Unlimited Co.
Court ruling from Court of Appeals for the Federal Circuit. Docket: 25-1998
May 18, 2026
dark_pool
Dark Pool: MDT — 12.1M shares, 158,736 trades
Week starting 2026-05-18. Total ATS volume: 12,096,822 shares across 158,736 trades.
May 11, 2026
dark_pool
Dark Pool: MDT — 12.4M shares, 158,152 trades
Week starting 2026-05-11. Total ATS volume: 12,426,175 shares across 158,152 trades.
May 4, 2026
dark_pool
Dark Pool: MDT — 11.0M shares, 131,898 trades
Week starting 2026-05-04. Total ATS volume: 11,017,457 shares across 131,898 trades.
Apr 27, 2026
dark_pool
Dark Pool: MDT — 11.2M shares, 137,945 trades
Week starting 2026-04-27. Total ATS volume: 11,186,327 shares across 137,945 trades.
Apr 20, 2026
dark_pool
Dark Pool: MDT — 11.5M shares, 130,855 trades
Week starting 2026-04-20. Total ATS volume: 11,544,172 shares across 130,855 trades.
Apr 13, 2026
dark_pool
Dark Pool: MDT — 10.4M shares, 132,566 trades
Week starting 2026-04-13. Total ATS volume: 10,435,605 shares across 132,566 trades.
Apr 10, 2026
short_interest
FTD: MDT — 10,506 shares ($0.9M) failed to deliver
Settlement: 20260410, Price: $87.91, FTD Value: $923,582.46, MEDTRONIC PLC ORD SHS (IRL)
Apr 6, 2026
dark_pool
Dark Pool: MDT — 11.1M shares, 136,109 trades
Week starting 2026-04-06. Total ATS volume: 11,091,196 shares across 136,109 trades.
Apr 6, 2026
Enforcement
Staggers v. Medtronic, Inc.
Court ruling from District Court, District of Columbia. Docket: Civil Action No. 2015-0392
Mar 30, 2026
dark_pool
Dark Pool: MDT — 5.8M shares, 94,669 trades
Week starting 2026-03-30. Total ATS volume: 5,768,620 shares across 94,669 trades.
Mar 23, 2026
dark_pool
Dark Pool: MDT — 10.2M shares, 139,271 trades
Week starting 2026-03-23. Total ATS volume: 10,227,113 shares across 139,271 trades.
Mar 23, 2026
short_interest
FTD: MDT — 60,847 shares ($5.2M) failed to deliver
Settlement: 20260323, Price: $86.16, FTD Value: $5,242,577.52, MEDTRONIC PLC ORD SHS (IRL)
Mar 16, 2026
dark_pool
Dark Pool: MDT — 7.5M shares, 120,821 trades
Week starting 2026-03-16. Total ATS volume: 7,520,107 shares across 120,821 trades.
Mar 9, 2026
dark_pool
Dark Pool: MDT — 11.8M shares, 152,904 trades
Week starting 2026-03-09. Total ATS volume: 11,774,992 shares across 152,904 trades.